SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sim, J. S.
Right arrow Articles by Struthers, A. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sim, J. S.
Right arrow Articles by Struthers, A. D
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Statin therapy increases vascular sensitivity to angiotensin II in hypercholesterolaemic patients

Justein SN Sim

Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK

John BC Dick

Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK

Allan D Struthers

Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK, a.d.struthers{at}dundee.ac.uk

Introduction Cross-talk between various cardiovascular risk factors has been suggested by a number of studies. This study examines the interaction between hypercholesterolaemia and the renin-angiotensin system in vivo in man.

Methods We performed a randomised, placebo-controlled, double-blind crossover study on 40 hypercholesterolaemic patients, comparing cholesterol-lowering therapy with a statin for six months versus placebo. Brachial artery function was assessed by bilateral venous occlusion plethysmography using intra-arterial infusions of the endothelial-dependent vasoconstrictors, angiotensin I (Ang I) and angiotensin II (Ang II), to measure vascular angiotensin-converting enzyme (ACE) and Ang II receptor response respectively. The endothelial-independent vasoconstrictor, noradrenaline, was used as a control vasoconstrictor. Results were analysed by multiple analysis of variance and statistical significance

Cholesterol-lowering treatment with a statin was taken as a p value <0.05. Results Cholesterol-lowering treatment with alstatin significantly reduced the mean total cholesterol level to 5.71 mmol/L vs. 7.57 mmol/L on placebo (p<0.0001). Hypercholesterolaemia significantly increased the vasoconstriction response to noradrenaline (placebo versus statin treatment; p=0.046). In hypercholesterolaemia, there was a strong trend towards a reduction in the vasoconstriction response to Ang I (placebo versus statin treatment; p=0.089). In hypercholesterolaemia, the vasoconstriction response to Ang II was significantly reduced (placebo versus statin treatment; p=0.01).

Conclusions Our in vivo results show that, unlike some other previous work, hypercholesterolaemia is associated with down-regulation of the vasoconstrictor response to Ang II and that statin therapy up-regulates the local vasoconstrictor response to Ang II. The possibility now arises that, in man, statins alter the balance between AT1-receptors and AT2-receptors.

Key Words: Hypercholesterolaemia • angiotensin • statins

References

  • Vita JA,Treasure CB, Nabel EG et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;8:491-7.
  • Raij L. Hypertension, endothelium, and cardiovascular risk factors. Am J Med 1991;90(suppl 2A):13S-18S.[CrossRef][Medline] [Order article via Infotrieve]
  • Preik M., Kelm M., Rosen P.,Tschope D., Strauer BE Additive effect of coexistent type 2 diabetes and arterial hypertension on endothelial dysfunction in resistance arteries of human forearm vasculature. Angiology 2000;51:545-54.[Web of Science][Medline] [Order article via Infotrieve]
  • Heitzer T., Yla-Herttuala S., Luoma J. et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolaemia. Role of oxidized LDL. Circulation 1996;93:1346-53.[Abstract/Free Full Text]
  • The Heart Outcomes Prevention Evaluation Study Investigators. Effect of an ACE inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000;342:14553.
  • Pfeffer MA, Braunwald E., Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. N Engl J Med G 1992;327:66977.
  • Pedersen TR and the Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Shepherd J., Cobbe SM, Ford I. et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995;333:1301-07.[Abstract/Free Full Text]
  • Zdrojewicz Z., Januszewski A., Zareba-Bogdal E., Karwacki J., Plamieniak Z. Activity of converting enzyme angiotensin I to angiotensin II in patients with diabetes type II. Pol Arch Med Wewn 1995;93:305-13.[Medline] [Order article via Infotrieve]
  • Walker WG Relation of lipid abnormalities to progression of renal damage in essential hypertension, insulin dependent and non insulin dependent diabetes mellitus. Miner Electrolyte Metals 1993;19:137-43.
  • Chobanian AV, Haudenschile CC, Nickerson C., Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidaemic rabbit. Hypertension 1990;15:327-31.[Abstract/Free Full Text]
  • Lee AFC, Dick JBC, Bonnar CE, Struthers AD Lisinopril improves arterial function in hypercholesterolaemia. Clin Sci 1999;96:441-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Diet FP, Pratt RE, Berry GJ, Momose N., Gibbons GH, Dzau VJ Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996;94:2756-67.[Abstract/Free Full Text]
  • Nickenig G., Sachinidis A., Michaelsen F., Bohm M., Seewald S., Vetter H. Upregulation of vascular angiotensin II receptor gene expression by low density lipoprotein in vascular smooth muscle cells. Circulation 1997;95:473-8.[Abstract/Free Full Text]
  • Keidar S., Kaplan M.,Aviram M. Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation. Arteriosclerosis Thromb Vasc Biol 1996;16:97-105.[Abstract/Free Full Text]
  • Nickenig G., Jung O., Strehlow K. et al. Hypercholesterolaemia is associated with enhanced angiotensin AII, receptor expression. Am J Physiol 1997;72:H2701-H2707.
  • Straznicky NE, Howes LG, Lam W., Louis WJ Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolaemia and systemic hypertension. Am J Cardiol 1995;75:582-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Davidson NC, Barr CS, Struthers AD C-type natriuretic peptide: an endogenous inhibitor of vascular angiotensin-converting enzyme activity. Circulation 1996;93:1155-9.[Abstract/Free Full Text]
  • Greenfield ADM, Paterson GC Reactions of the blood vessels of the human forearm to increases in transmural pressure. J Physiol (Lond) 1954;125:508-24.[Free Full Text]
  • Nickenig G., Baumer AT, Temur Y., Kebben D., Jockenhovel F., Bohm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation 1999; 100:2131-4.[Abstract/Free Full Text]
  • Seeger H., Mueck AO, Lippert TH Fluvastatin increases prostacyclin and decreases endothelin production by human umbilical vein endothelial cells. Int J Clin Pharmacol Ther 2000;38:270-2.[Web of Science][Medline] [Order article via Infotrieve]
  • Hernandez-Perera O., Perez-Sala D., Navarro-Antolin J. et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 1998;101:2711-19.[Web of Science][Medline] [Order article via Infotrieve]
  • Laufs U., La Fata V., Plutzky J., Liao JK Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998;97:1129-35.[Abstract/Free Full Text]
  • Mitani H., Bandoh T., Ishikawa J., Kimura M., Totsuka T., Hayashi S. Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits. Br J Pharmacol 1996;119:1269-75.[Web of Science][Medline] [Order article via Infotrieve]
  • Wassmann S., Laufs U., Baumer AT et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolaemic hypertension via reduced production of reactive oxygen species. Hypertension 2001;37:1450-7.[Abstract/Free Full Text]
  • Cahill PA, Redmond EM, Foster C., Sitzmann JV Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cells. Dur J Pharmacol 1995;288:219-29.
  • Katugampola SD, Davenport AP Changes in ET(A)-, AT1 and AT2-receptors in the phenotypically transformed intimal smooth muscle layer of human atherosclerotic coronary arteries. J Cardiovasc Pharmacol 2000;36(suppl 1):S395-S396.[Web of Science][Medline] [Order article via Infotrieve]
  • Spieker LE, Corti R., Binggeli C., Luscher T., Noll G. Baroreceptor dysfunction induced by NO synthase inhibition in humans. J Am Coll Cardiol 2000;36:213-18.[Abstract/Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 5, No. 3, 109-113 (2004)
DOI: 10.3317/jraas.2004.026


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sim, J. S.
Right arrow Articles by Struthers, A. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sim, J. S.
Right arrow Articles by Struthers, A. D
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement